Guardian Capital Announces Final ETF Valuations
March 15, 2024 17:15 ET
|
Guardian Capital LP
TORONTO, March 15, 2024 (GLOBE NEWSWIRE) -- Guardian Capital LP (the “Manager”) today announced the final valuation of Guardian Fundamental All Country Equity ETF (TSX: GGAC) and Guardian...
Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
March 13, 2024 07:30 ET
|
Clearmind Medicine Inc.
Vancouver, Canada, March 13, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development...
Successful Inaugural Trading Session on ARTEX Stock Exchange
March 09, 2024 05:47 ET
|
ARTEX Stock Exchange
PR REF: ARTX/01 2024 Vaduz, Saturday 09 March 2024 ARTEX MTF, the exchange for art shares trading, is pleased to announce the successful first trading session. This first short session marked a...
Successful completion of the initial offering on the iconic artwork from Francis Bacon 'Three Studies for Portrait of George Dyer, 1963’
March 07, 2024 04:24 ET
|
Art Share 002
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
Affimed Announces 1-for-10 Reverse Stock Split
March 06, 2024 06:30 ET
|
Affimed N.V.
MANNHEIM, Germany, March 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their...
Extension of the Offer Period
March 05, 2024 09:32 ET
|
Art Share 002
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, SOUTH AFRICA OR ANY OTHER STATE OR...
Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 04, 2024 08:30 ET
|
Entera Bio Ltd.
JERUSALEM, March 04, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, announced today that it received...
Music Licensing, Inc. Clears "Shell Risk" Designation from OTC Markets Group Profile
March 01, 2024 08:37 ET
|
Music Licensing, Inc.
Naples, FL, March 01, 2024 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG), a diversified holding company, proudly announces the removal of the long-disputed "Shell Risk" designation from its...
ATHA Energy Announces Approval to List on TSXV and Receipt of Final Order for Arrangement With Latitude Uranium
March 01, 2024 07:00 ET
|
ATHA Energy Corp.
VANCOUVER, British Columbia, March 01, 2024 (GLOBE NEWSWIRE) -- ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or the “Company”) is pleased to announce that it received final...
Absci Announces Pricing of Public Offering of Common Stock
February 27, 2024 22:20 ET
|
Absci Corporation
VANCOUVER, Wash., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI) (“Absci”), a data-first generative AI drug creation company, today announced the pricing of an underwritten...